XML 57 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727
Note D - Stock-Based Compensation
6 Months Ended
Jun. 30, 2015
Disclosure Text Block Supplement [Abstract]  
Compensation and Employee Benefit Plans [Text Block]

NOTE D: STOCK BASED COMPENSATION


The Company maintains a stock option plan under which incentive stock options and nonqualified stock options may be granted. On March 2, 2006, the Company’s Board of Directors (the “Board”) adopted, and shareholders later approved, the 2006 Stock Option Plan (the “2006 Plan”). Under the 2006 Plan, 750,000 shares were reserved for the issuance of stock options to directors, officers, key employees, and others. The option exercise price under the 2006 Plan is the fair market value of the stock on the date the option is granted. The fair market value is determined by the closing price of the Company’s common stock, on its primary exchange, on the same date that the option is granted. On March 13, 2014, the Company’s Board of Directors adopted, and on May 29, 2014 our shareholders approved, the 2014 Amended and Restated Stock Option and Incentive Plan (the “2014 Plan”) which replaced the 2006 Plan. The shares which remained reserved under the 2006 Plan were carried over to the 2014 Plan and are reserved for the issuance of stock awards to directors, officers, key employees, and others. Stock option exercise price under the 2014 Plan is the fair market value of the stock on the date the option is granted. The restricted stock purchase price under the 2014 Plan shall not be less than 85% of the fair market value of the Company’s common stock on the date the award is made. The fair market value is determined by the average of the highest and lowest sales prices for a share of the Company’s common stock, on its primary exchange, on the same date that the option or award is granted.


Outstanding nonqualified stock options at June 30, 2015, must be exercised within either five or ten years from the date of grant. Outstanding nonqualified stock options granted to members of the Company’s Board of Directors are fully vested while outstanding nonqualified stock options issued to employees vest in increments of 20% each year.


During the first six months of 2015, 1,225 shares of common stock were granted to non-employee directors under the 2014 Plan. This stock award had a grant date fair value of $57.27 per share, based on the closing price of the Company’s stock on the date of grant, and vested immediately.


The total grant date fair value of stock and stock options vested during the first six months of 2015 was approximately $154,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the second quarter of 2015 was approximately $49,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first six months of 2015 was approximately $169,000 and includes approximately $70,000 recognized as a result of the grant of 175 shares to each non-employee director during the first quarter of 2015. The recognition of stock-based compensation expense decreased diluted earnings per share reported for the second quarter ending June 30, 2015 by approximately $0.01 but did not have a recognizable impact on basic earnings per share reported for the second quarter ended June 30, 2015. The recognition of stock-based compensation expense decreased diluted and basic earnings per common share by approximately $0.01 during the six months ended June 30, 2015. As of June 30, 2015, the Company had stock-based compensation plans with total unvested stock-based compensation expense of approximately $443,000 which is being amortized on a straight-line basis over the remaining vesting period. As a result, the Company expects to recognize approximately $99,000 in additional compensation expense related to unvested option awards during the remainder of 2015 and to recognize approximately $167,000, $109,000, and $68,000 in additional compensation expense related to unvested option awards during the years 2016, 2017, and 2018, respectively.


The total grant date fair value of stock and stock options vested during the first six months of 2014 was approximately $144,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the second quarter of 2014 was approximately $30,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first six months of 2014 was approximately $115,000 and included approximately $60,000 recognized as a result of the grant of 504 shares to each non-employee director during the first quarter of 2014. The recognition of stock-based compensation expense did not have a recognizable impact on diluted or basic earnings per share reported for the second quarter ending June 30, 2014, but did decrease diluted and basic earnings per common share by approximately $0.01 during the six months ending June 30, 2014.


Information related to stock option activity for the six months ended June 30, 2015 is as follows:


   

Shares Under Options

   

Weighted-Average Exercise Price

   

Weighted- Average Remaining Contractual Term

   

Aggregate Intrinsic Value*

 
           

(per share)

   

(in years)

         

Outstanding at January 1, 2015

    86,348     $ 11.09                  

Granted

    -       -                  

Exercised

    (19,800 )     11.66                  

Cancelled/forfeited/expired

    -       -                  

Outstanding at June 30, 2015

    66,548     $ 10.92       4.7     $ 3,136,135  
                                 

Exercisable at June 30, 2015

    32,239     $ 10.88       2.5     $ 1,520,612  

* The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The per share market value of our common stock, as determined by the closing price on June 30, 2015, was $58.05.


A summary of the status of the Company’s nonvested options and restricted stock as of June 30, 2015 and changes during the six months ended June 30, 2015, is presented below:


Stock Options:


   

Number of Options

   

Weighted- Average Grant Date Fair Value

 
                 

Nonvested at January 1, 2015

    48,109     $ 6.10  

Granted

    -       -  

Canceled/forfeited/expired

    -       -  

Vested

    (13,800 )     6.06  

Nonvested at June 30, 2015

    34,309     $ 6.11  

Restricted Stock:


   

Number of Options

   

Weighted- Average Grant Date Fair Value

 
                 

Nonvested at January 1, 2015

    7,600     $ 42.65  

Granted

    1,225       57.27  

Canceled/forfeited/expired

    -       -  

Vested

    (1,225 )     57.27  

Nonvested at June 30, 2015

    7,600     $ 42.65  

The number, weighted average exercise price, and weighted average remaining contractual life of options outstanding as of June 30, 2015 and the number and weighted average exercise price of options exercisable as of June 30, 2015 are as follows:


Exercise Price

   

Shares Under Outstanding Options

   

Weighted-Average Remaining Contractual Term

   

Shares Under Exercisable Options

 
               

(in years)

         
$ 10.44       15,000       2.7       15,000  
$ 10.90       6,000       1.9       6,000  
$ 10.90       29,600       6.9       2,000  
$ 11.22       7,948       5.4       1,239  
$ 11.54       4,000       1.7       4,000  
$ 11.75       4,000       0.7       4,000  
          66,548       4.7       32,239  

Cash received from option exercises totaled approximately $231,000 and $463,000 during the six months ended June 30, 2015 and June 30, 2014, respectively. The Company issues new shares upon option exercise.